SCHEMBL13110435

SCHEMBL13110435

COC(=O)Cc1coc2cc(OCc3cccc(Oc4ccccc4)c3)ccc12

nearest known ligand 0.60

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.59
PPARD Q03181 3/20 0.57
PPARA Q07869 2/20 0.57
PPARG P37231 1/20 0.57
LTA4H P09960 2/20 0.49
PLA2G2A P14555 2/20 0.49
FFAR4 Q5NUL3 1/20 0.47
MAPT P10636 2/20 0.47
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3450768 0.90 PPARD (0.70) FFAR1PPARDPPARAPPARGFFAR4
SCHEMBL5638404 0.85 PPARD (0.72) FFAR1PPARDPPARAPPARG
SCHEMBL13110438 0.82 FFAR1 (0.82) FFAR1PPARDPPARAPPARGFFAR4
SCHEMBL10239132 0.80 PPARD (0.60) FFAR1PPARDPPARAPPARGMAPT
SCHEMBL5639128 0.77 PPARD (0.79) FFAR1PPARDPPARAPPARG
SCHEMBL2431256 0.77 ALDH1A1 (0.67) MAPTALDH1A1L3MBTL1
SCHEMBL9749438 0.75 MAOB (0.56) FFAR1PPARDPPARAPPARG
SCHEMBL5639006 0.75 PPARD (0.89) FFAR1PPARDPPARAPPARGFFAR4
SCHEMBL5638003 0.75 PPARD (0.66) FFAR1PPARDPPARAPPARGMAPT
SCHEMBL15211552 0.74 POLB (0.51) FFAR1PPARDPPARAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820837-B2 ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-10-26 US disclosed
US-7820837-B2 ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-10-26 US disclosed